Department of Vascular Surgery, Sakakibara Heart Institute, Japan Research Promotion Society for Cardiovascular Diseases, Tokyo, Japan.
Circ J. 2012;76(6):1380-4. doi: 10.1253/circj.cj-11-1511. Epub 2012 Mar 13.
Patients with both cardiothoracic lesions and abdominal aortic aneurysm (AAA) are increasing in Japan. The objective of this study was to clarify the effect of 2-staged surgery on complication rates.
Three hundred and forty-six patients who underwent elective surgery for infrarenal AAA were entered. History of cardiac and thoracic aortic surgery within 1 year before AAA repair was recorded. A retrospective study regarding perioperative complications was performed. Operative mortality and complication rates were 0.6% and 10.7%, respectively. Seventy patients (20.2%) underwent prior cardiac and thoracic aortic surgery before AAA repair. There was no significant difference in preoperative characteristics between the group with prior cardiac and thoracic aortic surgery and the group without prior surgery. Significant risk factors for postoperative morbidity were: (1) prior cardiac and thoracic aortic surgery (odds ratio [OR] 2.5; 95%CI 1.1-5.1); (2) open aneurysm repair (OAR) (OR 2.7; 95%CI 1.3-5.1); and (3) VSG-CRI score ≥6 (OR 2.9; 95%CI 1.2-6.8). Subanalysis revealed that, although prior cardiac and thoracic aortic surgery was still a risk within patients undergoing OAR, it was not a risk factor for patients undergoing endovascular aneurysm repair (EVAR).
Prior cardiac and thoracic aortic surgery carries high risk for AAA repair. To lower complication rates, we propose to perform EVAR on these patients if they are anatomically suitable.
日本患有心胸病变和腹主动脉瘤(AAA)的患者数量不断增加。本研究旨在阐明两阶段手术对并发症发生率的影响。
本研究纳入了 346 例因肾下型 AAA 择期手术的患者。记录了在 AAA 修复前 1 年内进行的心脏和胸主动脉手术史。对围手术期并发症进行了回顾性研究。手术死亡率和并发症发生率分别为 0.6%和 10.7%。70 例(20.2%)患者在 AAA 修复前曾行心脏和胸主动脉手术。两组患者在术前特征方面无显著差异。术后发病率的显著危险因素为:(1)既往心脏和胸主动脉手术史(比值比 [OR] 2.5;95%置信区间 [CI] 1.1-5.1);(2)开放型动脉瘤修复术(OAR)(OR 2.7;95%CI 1.3-5.1);和(3)VSG-CRI 评分≥6(OR 2.9;95%CI 1.2-6.8)。亚组分析显示,尽管既往心脏和胸主动脉手术仍然是 OAR 患者的风险因素,但对于接受血管内动脉瘤修复术(EVAR)的患者并非风险因素。
既往心脏和胸主动脉手术会增加 AAA 修复的风险。为了降低并发症发生率,如果这些患者解剖结构合适,我们建议行 EVAR。